RBC Europe’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
RBC Europe's LLY Position: Q2 2022 in Review
RBC Europe reduced its Eli Lilly (LLY) stake by 33% in Q2 2022, selling an estimated $832K and leaving 5,648 shares worth $1.83M. The position accounts for 0.09% of the portfolio, ranked #84.
RBC Europe first reported a position in LLY in Q3 2017 and has held it in 20 quarters since. The position peaked at $14.4M in Q3 2021. 2,446 funds tracked by Wall St. Rank hold LLY as of Q2 2022.
- RBC Europe held 5,648 shares of Eli Lilly worth $1.83M as of Q2 2022.
- RBC Europe sold 2,772 Eli Lilly shares in Q2 2022, an estimated $832K.
- Eli Lilly made up 0.09% of RBC Europe's portfolio in Q2 2022, its #84 holding.
- RBC Europe first reported a position in Eli Lilly in Q3 2017 and has held it in 20 quarters since.
- RBC Europe's Eli Lilly position peaked at $14.4M in Q3 2021.
- 2,446 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2022.
Based on RBC Europe's 13F filing for Q2 2022, filed 14 Nov 2022.